Buy & Sell Abbott Laboratories (ABT) – Abbott Laboratories Price Today
Aura AI Summary
Key Stats
- $163.94BMarket Cap
- HealthSector
- -20.31%3M Drawdown
- $190.69BEnterprise Value
- 2.68%Dividend Yield
- 41% Buy | 59% SellTrading Activity
- 93 daysTypical Hold Time
Abbott Laboratories (ABT) is currently valued at a market capitalization of $163.94B, with an enterprise value of $190.69B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $136.62, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -20.31%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 2.68%, with the most recent dividend of $0.63 paid on 15 Apr 26. On average, investors hold Abbott Laboratories for approximately 93 days, indicating typical investor behavior on the platform.
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Most Recent News
Fidelity Advisor Series VIII increases voting rights in Renk Group AG to 3.23%.
Fidelity Advisor Series VIII, based in Boston, has raised its voting rights stake in Renk Group AG to 3.23% as of June 24, 2026. This includes 3.04% direct voting rights and 0.19% through stock loan instruments. The total voting rights are based on 1...

Fidelity Advisor Series VIII increases stake in Renk Group AG to 3.23%
Fidelity Advisor Series VIII has increased its voting rights in Renk Group AG to 3.23% as of June 24, 2026. This includes 3.04% voting rights attached to shares and 0.19% through stock loan instruments. The total voting rights represent a significant...

No buybacks of cooperative investment certificates reported by CRCAM Toulouse for week of June 22-26, 2026
CRCAM Toulouse announced that no repurchases of its cooperative investment certificates (CCI) were made during the week of June 22 to June 26, 2026. This update is part of their regular weekly disclosure on CCI transactions, reflecting no activity in...
